dc.contributor.author |
Hakki, Shilpa Anand |
|
dc.date.accessioned |
2020-12-17T04:36:26Z |
|
dc.date.available |
2020-12-17T04:36:26Z |
|
dc.date.issued |
2018-05 |
|
dc.identifier.citation |
Journal of Evidence Based Medicine and Healthcare. 2018 May; 5(21): 1660-1663. |
en_US |
dc.identifier.issn |
2349-2562 |
|
dc.identifier.uri |
http://localhost/xmlui/handle/123456789/1520 |
|
dc.language.iso |
en |
en_US |
dc.publisher |
Level Up Business Center |
en_US |
dc.subject |
Nephrotic syndrome-chemically induced |
|
dc.subject |
Nephritis, interstitial |
|
dc.subject |
Necrosis-chemically induced |
|
dc.subject |
Hyperkalemia-chemically induced |
|
dc.subject |
Glomerular filtration rate |
|
dc.subject |
Anti-inflammatory agents, non-steroidal |
|
dc.title |
NSAID induced nephropathy |
en_US |
dc.type |
Article |
en_US |